UNITY Biotechnology (UBX) Announces CFO Transition

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. NVDA
3. SBUX
4. SPY
5. GOOGL
6. APLD
7. USO
8. STZ
9. AGNT
10. ORCL

Go back to UNITY Biotechnology (UBX) Announces CFO Transition

UNITY Biotechnology Announces CFO Transition

July 6, 2020 5:00 PM EDT

SAN FRANCISCO, July 06, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that Bob Goeltz, chief financial officer, will leave the company at the end of July 2020 to pursue a new opportunity. Effective August 1, 2020, Lynne Sullivan, former senior vice president of Biogen, Inc. (Biogen), will become UNITYs interim chief financial officer.

I want to thank Bob for his many contributions and wish him success in his next endeavors, said Anirvan Ghosh, Ph.D., chief executive officer of UNITY. We have a... More